Ramesh Kale

Employment

Employment history is unavailable.

Education

• NIPER M.S.(Pharm)
  2008 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors
  Biochemical and Biophysical Research Communications 2024 DOI: 10.1016/j.bbrc.2024.150348
  +Save
• Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling
  Biomedical Reports 2023 DOI: 10.3892/br.2023.1676
  +Save
• PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways.
  Biochemistry and biophysics reports 2023 DOI: 10.1016/j.bbrep.2023.101544
  +Save
• Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models: Discovery and preclinical characterization of LL-00084282.
  Biochemical and biophysical research communications 2022 DOI: 10.1016/j.bbrc.2022.11.038
  +Save
• Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization.
  Bioorganic & medicinal chemistry 2020 DOI: 10.1016/j.bmc.2020.115819
  +Save